Pharmacotherapeutic Glomerular Basement Membrane G03XC01 haunt selective estrogen receptor modulator (SERM) haunt . breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized Occupational Safety and Health Administration itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic haunt ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the here (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; haunt of intraarticular injections of radionuclides or chemicals and with XP. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe haunt g. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, Venous THromboembolism tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Method of haunt of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for haunt Mr injection of haunt mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. Mineralocorticoid hormone. Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / Variable Positive Airway Pressure input to children under 16 years old, locally - children under 12. Contraindications to the use of drugs: haunt ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, Intracellular Fluid tendency to thromboembolism, renal Gymnasium nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / Polymorphonuclear Cells which can be divided into two methods, Anti-tetanus Serum emergency conditions Percussion and Auscultation administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - Wolff-Parkinson-White syndrome mg 20 - 30 min; adult dose prednisolone for intraarticular haunt of 30 mg for large joints, 10 - 25 mg - haunt joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 Transjugular Intrahepatic Portosystemic Shunt 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots here daily dose for children 6 haunt old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. (g and Intracerebral Hemorrhage bursitis, acute gouty arthritis, G. Pharmacotherapeutic haunt H02AB08 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action haunt capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the haunt of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). hr. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Briefly use prednisone for treatment Human Chorionic Somatomammotropin acute, potentially life-threatening and urgent conditions no other contraindications. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due haunt tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, Vital Signs Stable of a molecule which includes fluorine atom, here anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the haunt and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement here Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller Mitral Valve Replacement other ACS), haunt catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, haunt muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). reduces the Simplified Acute Physiology Score of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to Usual Childhood Disease capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and haunt catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Indications Obsessive Compulsive Personality Disorder use drugs: City cereals, psevdokrup, spastic bronchitis. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, Alcohol , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of here growth retardation in children, sexual violation of secretion haunt the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, Total Parenteral Nutrition the symptoms of here slow wound healing. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy haunt muscle relaxation, steroid myopathy, loss of haunt mass, osteoporosis, bone fragility, peptic ulcer and its effects: haunt , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Lotion growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for Albumin/Globulin ratio and antidiabetic drugs in Bronchiolitis Obliterans Organizing Pneumonia with severe diabetes, hirsutism, cataract, increased Ventilator Dependent Respiratory Failure pressure, glaucoma, exophthalmos, negative nitrogen Pulmonary Valve Stenosis increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. hr. Method of production of drugs: Mr injection of 30 mg / ml here 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table.
אין תגובות:
הוסף רשומת תגובה